Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Attar Eyal C. | 0001789076 | Oct-11-2022 | officer: Chief Medical Officer |
RA Capital Healthcare Fund LP | 0001315082 | Feb-04-2021 | director, 10 percent owner |
RA CAPITAL MANAGEMENT, L.P. | 0001346824 | Feb-04-2021 | director, 10 percent owner |
Kolchinsky Peter | 0001384859 | Feb-04-2021 | director, 10 percent owner |
Patterson Matthew R | 0001401018 | Feb-04-2021 | director |
Beckman Daniella | 0001513422 | Feb-04-2021 | director |
Lubner David Charles | 0001572000 | Feb-04-2021 | director |
Schwab Andrew J. | 0001598549 | Feb-04-2021 | 10 percent owner |
Shah Rajeev M. | 0001619841 | Feb-04-2021 | director, 10 percent owner |
PARMAR KUSH | 0001664281 | Feb-04-2021 | director, 10 percent owner |
Lundberg Sven Ante | 0001682126 | Feb-04-2021 | director |
Resnick Joshua | 0001690959 | Feb-04-2021 | director |
Alexandria Venture Investments, LLC | 0001722024 | Feb-04-2021 | 10 percent owner |
PureTech Health LLC | 0001727395 | Feb-04-2021 | 10 percent owner |
ANG ROBERT | 0001741283 | Feb-04-2021 | director, officer: President and CEO |
5AM Opportunities I, L.P. | 0001753000 | Feb-04-2021 | 10 percent owner |
5AM Ventures VI, L.P. | 0001753037 | Feb-04-2021 | 10 percent owner |
5AM Opportunities I (GP), LLC | 0001790778 | Feb-04-2021 | 10 percent owner |
5AM Partners VI, LLC | 0001829051 | Feb-04-2021 | 10 percent owner |
Chakraborty Tirtha | 0001840685 | Feb-04-2021 | officer: Chief Scientific Officer |
Kassim Sadik | 0001840726 | Feb-04-2021 | officer: Chief Technology Officer |
Slapak Christopher | 0001841150 | Feb-04-2021 | officer: Chief Medical Officer |
Jorgensen Nathan D. | 0001842523 | Feb-04-2021 | officer: Chief Financial Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Vor Biopharma Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
ARS | Document | Annual report to security holders Acc-no: 0001193125-24-090803 (34 Act) Size: 1425 KB |
Apr-09-2024 | 24832821 |
DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001193125-24-090792 (34 Act) Size: 819 KB |
Apr-09-2024 | 24832782 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001193125-24-090781 (34 Act) Size: 1119 KB |
Apr-09-2024 | 24832743 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-072926 (33 Act) Size: 75 KB |
Mar-21-2024 | 24768907 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-24-034146 (34 Act) Size: 9145 KB |
Mar-20-2024 | 24767739 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-006594 ( Act) Size: 4 KB |
Mar-05-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-006593 ( Act) Size: 4 KB |
Mar-05-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-006592 ( Act) Size: 4 KB |
Mar-05-2024 | |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-24-023684 (34 Act) Size: 102 KB |
Feb-14-2024 | 24638549 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-023625 (34 Act) Size: 58 KB |
Feb-14-2024 | 24637990 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001525 (34 Act) Size: 8 KB |
Feb-09-2024 | 24612642 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-003041 ( Act) Size: 4 KB |
Feb-08-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-003038 ( Act) Size: 4 KB |
Feb-08-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-003036 ( Act) Size: 4 KB |
Feb-08-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-003033 ( Act) Size: 4 KB |
Feb-08-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-002104 ( Act) Size: 7 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-002101 ( Act) Size: 7 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-002098 ( Act) Size: 7 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-002096 ( Act) Size: 7 KB |
Jan-31-2024 | |
8-K | Document | Current report filing Acc-no: 0001193125-24-003459 (34 Act) Size: 4211 KB |
Jan-05-2024 | 24517404 |
Recent 20 filings. View all Vor Biopharma Inc. filings
Huge help thank you for your help .. y'all make it so much easier
It's being easier working on the website. And I recommend, it's a great website
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by